PharmAla Advances ALA-002 Drug Development with Canadian GMP Manufacturing Agreement
Canadian biotechnology company PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) has signed an agreement with Corealis Pharma Inc., a ...
Canadian biotechnology company PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) has signed an agreement with Corealis Pharma Inc., a ...
New Zealand medicinal cannabis company Rua Bioscience has signed a distribution agreement with PharmAla Biotech, following the country's first approvals ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
